Barclays’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.96M | Buy |
425,981
+185,333
| +77% | +$2.59M | ﹤0.01% | 1494 |
|
2025
Q1 | $3.27M | Sell |
240,648
-37,419
| -13% | -$508K | ﹤0.01% | 1709 |
|
2024
Q4 | $5.67M | Buy |
278,067
+22,184
| +9% | +$452K | ﹤0.01% | 1491 |
|
2024
Q3 | $7.45M | Buy |
255,883
+128,823
| +101% | +$3.75M | ﹤0.01% | 1214 |
|
2024
Q2 | $2.95M | Sell |
127,060
-24,500
| -16% | -$569K | ﹤0.01% | 1448 |
|
2024
Q1 | $3.11M | Sell |
151,560
-172,459
| -53% | -$3.54M | ﹤0.01% | 1638 |
|
2023
Q4 | $6.95M | Buy |
324,019
+157,512
| +95% | +$3.38M | ﹤0.01% | 1273 |
|
2023
Q3 | $3.44M | Buy |
166,507
+8,045
| +5% | +$166K | ﹤0.01% | 1346 |
|
2023
Q2 | $4.68M | Sell |
158,462
-497,965
| -76% | -$14.7M | ﹤0.01% | 1261 |
|
2023
Q1 | $15.1M | Buy |
656,427
+70,462
| +12% | +$1.62M | 0.01% | 681 |
|
2022
Q4 | $16.3M | Buy |
585,965
+260,498
| +80% | +$7.24M | 0.01% | 701 |
|
2022
Q3 | $9.99M | Sell |
325,467
-43,304
| -12% | -$1.33M | 0.01% | 817 |
|
2022
Q2 | $10.9M | Buy |
368,771
+310,639
| +534% | +$9.14M | 0.01% | 793 |
|
2022
Q1 | $1.87M | Sell |
58,132
-62,689
| -52% | -$2.02M | ﹤0.01% | 1824 |
|
2021
Q4 | $5.39M | Buy |
120,821
+49,856
| +70% | +$2.22M | ﹤0.01% | 1191 |
|
2021
Q3 | $3.58M | Buy |
70,965
+47,204
| +199% | +$2.38M | ﹤0.01% | 1442 |
|
2021
Q2 | $1.87M | Sell |
23,761
-66,012
| -74% | -$5.18M | ﹤0.01% | 1763 |
|
2021
Q1 | $5.13M | Buy |
89,773
+67,315
| +300% | +$3.84M | ﹤0.01% | 1173 |
|
2020
Q4 | $1.88M | Sell |
22,458
-6,356
| -22% | -$533K | ﹤0.01% | 1605 |
|
2020
Q3 | $1.03M | Sell |
28,814
-6,775
| -19% | -$243K | ﹤0.01% | 1905 |
|
2020
Q2 | $860K | Buy |
35,589
+17,619
| +98% | +$426K | ﹤0.01% | 2009 |
|
2020
Q1 | $314K | Sell |
17,970
-30,698
| -63% | -$536K | ﹤0.01% | 2354 |
|
2019
Q4 | $848K | Buy |
48,668
+4,218
| +9% | +$73.5K | ﹤0.01% | 2404 |
|
2019
Q3 | $681K | Buy |
44,450
+13,538
| +44% | +$207K | ﹤0.01% | 2456 |
|
2019
Q2 | $642K | Buy |
30,912
+17,184
| +125% | +$357K | ﹤0.01% | 2589 |
|
2019
Q1 | $319K | Buy |
+13,728
| New | +$319K | ﹤0.01% | 2823 |
|
2018
Q4 | – | Sell |
-17,071
| Closed | -$371K | – | 4152 |
|
2018
Q3 | $371K | Buy |
17,071
+15,833
| +1,279% | +$344K | ﹤0.01% | 2775 |
|
2018
Q2 | $19K | Sell |
1,238
-2,099
| -63% | -$32.2K | ﹤0.01% | 3662 |
|
2018
Q1 | $65K | Buy |
+3,337
| New | +$65K | ﹤0.01% | 3366 |
|